With PYC having just completed a $3mil reno to its Perth facility to conduct paid service for research and development, I think this is what Nick Woolf is referring to when he says PYC will soon be cash positive.
The upfront fees and the milestone payments from the Major's will just be the icing on the cake. But is looks to me that they are covering several bases and looking at income from several other methods not directly linked to any successful outcome of a new drug.
The facilities upgrade was necessitated from the demand from the drug companies to have PYC conduct testing and research to their requirements, and PYC will get paid regardless.
This gets better by the day and with recent media, and its baby sized cap, is starting to pack a lot of potential.
DYOR and great posts and research from peaceAkki and patrickm.
PYC Price at posting:
7.4¢ Sentiment: ST Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)